Zenith National Investigation PDF Print E-mail
February 19, 2010

Finkelstein Thompson LLP is investigating potential claims on behalfof shareholders of Zenith National Insurance Corp. ("Zenith" or the"Company") (NYSE: ZNT) arising from the Company's announcement of its intent to be acquired by Fairfax Financial Holdings Limited ("Fairfax").

OnFebruary 18, 2010, Zenith announced that it entered into a mergeragreement with Fairfax, in which Fairfax will purchase all common stockof the Company that it does not already own. Fairfax currently owns an8.23% stake in Zenith. Under the terms of the agreement, Zenithshareholders will receive $38.00 in cash for every share of Zenithstock that they own in an all-cash transaction valued at approximately$1.4 billion. The deal is expected to close in the second quarter of2010.

The investigation is focused on the potential unfairness ofthe price to Zenith shareholders, potential conflicts of interests onthe part of the Zenith board and management, and whether the Zenithboard took all appropriate steps to maximize shareholder value. Indeed,at least one analyst has set a price target for Zenith stock at $40.00per share.

If you are interested in discussing your rights as aZenith shareholder, or have information relating to this investigation,please contact Finkelstein Thompson's Washington, DC offices at (877)337-1050 or by email at This email address is being protected from spam bots, you need Javascript enabled to view it .